05.11.2012 Views

Model Organisms in Drug Discovery

Model Organisms in Drug Discovery

Model Organisms in Drug Discovery

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ear both dom<strong>in</strong>ant markers and recessive mutations that allow them to be<br />

followed easily dur<strong>in</strong>g stock ma<strong>in</strong>tenance and genetic crosses. Balancers are of<br />

tremendous utility for the isolation of mutations and for the ma<strong>in</strong>tenance of<br />

mutant stocks, as well as for genetic experiments. Few other multicellular<br />

experimental organisms have balancer chromosomes.<br />

Mutagenesis<br />

Random mutagenesis<br />

RESEARCH TOOLS IN DROSOPHILA STUDIES 103<br />

Random mutagenesis has been the cornerstone of Drosophila forward genetics<br />

(see Section 4.1; us<strong>in</strong>g Drosophila for drug target identification and validation).<br />

There are three major methods to <strong>in</strong>duce mutations <strong>in</strong> flies: chemical mutagens,<br />

radiation and transposons (Ashburner, 1989; Greenspan, 1997; Roberts, 1998).<br />

The most widely used chemical mutagen <strong>in</strong> Drosophila today is<br />

ethylmethanesulfonate (EMS), which is normally used to make po<strong>in</strong>t<br />

mutations although not all mutations derived from an EMS mutagenesis<br />

experiment are po<strong>in</strong>t mutations and chromosomal aberrations may occur.<br />

Because EMS only affects one strand of the DNA helix, an <strong>in</strong>duced mutation<br />

may be reverted or fixed after an additional round of DNA replication. Very<br />

often EMS <strong>in</strong>duces missense mutations and there is a 5–10% chance that the<br />

isolated mutations are conditional mutations. By comb<strong>in</strong><strong>in</strong>g EMS and the<br />

FLP/FRT mitotic recomb<strong>in</strong>ation system (see later section on analytical tools),<br />

high-throughput F1 genetic screens can be performed easily.<br />

X-ray radiation from X-ray tube and g-ray radiation from 60 Co or 137 Cs are<br />

normally used to <strong>in</strong>duce chromosome/DNA aberrations such as deletions,<br />

<strong>in</strong>versions, duplications and translocations.<br />

The advantage of chemical- and radiation-based mutagenesis is their<br />

relative non-selectivity on DNA sequence context, therefore the <strong>in</strong>duced<br />

mutations are more randomly distributed <strong>in</strong> the genome than other methods.<br />

If the aim of a genetic screen is to discover most of the genes that affect the<br />

assay phenotype, these types of mutagens, especially chemical mutagens,<br />

should be used. However, their major disadvantage is that the <strong>in</strong>duced<br />

mutations need to be mapped before know<strong>in</strong>g which genes are mutated.<br />

Mapp<strong>in</strong>g mutations is a very time-consum<strong>in</strong>g process, even with genome-wide<br />

SNP <strong>in</strong>formation (Hosk<strong>in</strong>s et al., 2001).<br />

Eng<strong>in</strong>eered transposons, such as the P element, hobo element and PiggyBac<br />

element (Handler and Harrell, 1999; Horn and Wimmer, 2000; Horn et al.,<br />

2002; Thibault, 2002), are used as mutagens for <strong>in</strong>sertional mutagenesis. The<br />

great advantage of us<strong>in</strong>g transposons as mutagens is that they also serve as<br />

DNA ‘tags’ <strong>in</strong> the mutated gene. By us<strong>in</strong>g the <strong>in</strong>verted polymerase cha<strong>in</strong><br />

reaction (PCR) method (Takagi et al., 1992), the location of mutations <strong>in</strong> the

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!